Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

Isabelle Ray‐Coquard, Claire Cropet, M. van Glabbeke, +14

Cancer Research

Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty

Philippe Gabríel Steg, Éric Bonnefoy, Sylvie Chabaud, +5

Circulation

Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf Deep Vein Thrombosis

L. Pinède, J. Ninet, P. Duhaut, +6

Circulation

Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group

Jean‐Yves Blay, Axel Le Cesne, Isabelle Ray‐Coquard, +14

Journal of Clinical Oncology

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Preliminary Results of GETUG-01

P. Pommier, Sylvie Chabaud, J. L. Lagrange, +12

Journal of Clinical Oncology

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial

Paul Sargos, Sylvie Chabaud, I. Latorzeff, +14

The Lancet Oncology

Surgical OncologyUrologyRadiation TherapyGenitourinary CancerMedicine +6

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

Florence Duffaud, Olivier Mir, Pascaline Boudou‐Rouquette, +16

The Lancet Oncology

OncologyAdult PatientsMetronomic TherapyClinical TrialsMetastatic Osteosarcoma +6

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial

Axel Le Cesne, Isabelle Ray‐Coquard, Binh Bui, +11

The Lancet Oncology

Gastrointestinal OncologyMedicineGastroenterologyPathologyOpen-label Multicentre +6

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

Gonzague de Pinieux, Marie Karanian, François Le Loarer, +51

PLoS ONE

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial

C. Carrié, Nicolas Magné, Patricia Burban-Provost, +19

The Lancet Oncology

Surgical OncologyUrologyRadiation TherapyGenitourinary CancerMedicine +6